A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days
Phase of Trial: Phase III
Latest Information Update: 05 Aug 2016
At a glance
- Drugs Clobetasol (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Promius Pharma
- 01 Aug 2016 Status changed from active, no longer recruiting to completed.
- 13 May 2016 Status changed from recruiting to active, no longer recruiting.
- 09 Dec 2015 Planned End Date changed from 1 Nov 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.